Follow
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Job DescriptionBusiness IntroductionAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system w
Job DescriptionBusiness IntroductionAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system w
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
IMPORTANTE: Por favor todas aquellas personas que estén interesadas en aplicar a esta beca deberán completar 2 solicitudes para poder ser considerados:1) A través del enlace de LinkedIn (Plataforma de GSK/ViiV Healthcare)2) A través del siguiente enlace de Talentoteca: Prácticas de De
IMPORTANTE: Por favor todas aquellas personas que estén interesadas en aplicar a esta beca deberán completar 2 solicitudes para poder ser considerados:1) A través del enlace de LinkedIn (Plataforma de GSK/ViiV Healthcare)2) A través del siguiente enlace de Talentoteca: Prácticas de De
INGENIERO/A DE PROYECTOS Ubicación: Aranda de Duero Indefinido Plazo para aplicar: 10/02/2026Quieres liderar proyectos de ingeniería que marcan la diferencia en planta En GSK buscamos un/a Ingeniero/a de Proyectos con iniciativa técnica y capacidad de ejecución para gestionar instala
INGENIERO/A DE PROYECTOS Ubicación: Aranda de Duero Indefinido Plazo para aplicar: 10/02/2026Quieres liderar proyectos de ingeniería que marcan la diferencia en planta En GSK buscamos un/a Ingeniero/a de Proyectos con iniciativa técnica y capacidad de ejecución para gestionar instala
IMPORTANTE: Por favor todas aquellas personas que estén interesadas en aplicar a esta beca deberán completar 2 solicitudes para poder ser considerados:1) A través del enlace de LinkedIn (Plataforma de GSK/ViiV Healthcare)2) A través del siguiente enlace de Talentoteca: Prácticas de Ma
IMPORTANTE: Por favor todas aquellas personas que estén interesadas en aplicar a esta beca deberán completar 2 solicitudes para poder ser considerados:1) A través del enlace de LinkedIn (Plataforma de GSK/ViiV Healthcare)2) A través del siguiente enlace de Talentoteca: Prácticas de Ma
Key Account Manager Hematology (Andalucía Occidental) Ubicación: Sevilla Fecha límite para aplicar: 10/02/2026Te gustaría impulsar el acceso a soluciones de alto valor en hematología y marcar la diferencia en la atención del paciente En GSK buscamos un/a Key Account Manager para Anda
Key Account Manager Hematology (Andalucía Occidental) Ubicación: Sevilla Fecha límite para aplicar: 10/02/2026Te gustaría impulsar el acceso a soluciones de alto valor en hematología y marcar la diferencia en la atención del paciente En GSK buscamos un/a Key Account Manager para Anda
Key Account Manager Hematology (Madrid y Castilla - La Mancha) Ubicación: Madrid Fecha límite para aplicar: 10/02/2026Te gustaría impulsar el acceso a soluciones de alto valor en hematología y marcar la diferencia en la atención del paciente En GSK buscamos un/a Key Account Manager p
Key Account Manager Hematology (Madrid y Castilla - La Mancha) Ubicación: Madrid Fecha límite para aplicar: 10/02/2026Te gustaría impulsar el acceso a soluciones de alto valor en hematología y marcar la diferencia en la atención del paciente En GSK buscamos un/a Key Account Manager p
安全性情報部はGSK Japanが販売している製品の副作用等の安全性情報を適切に入手できるよう対処し入手した情報を管理している部署ですPharmacovigilancePV安全性業務はGSK製品を使用する患者さんの安全を守る重要な仕事であり日本だけでなく世界各国で厳しい法規制が設けられています我々安全性部門の業務はこれら法規制を守りながらGSK製品の安全性情報を収集評価し適切な対策を実施することですまたAIや自動化の技術を取り入れる等最適なプロセスの構築や効率化を図ることも会社として重要な取り組みとしているためこれらを前向きに業務に取り入れて運用出来る姿勢のある方
安全性情報部はGSK Japanが販売している製品の副作用等の安全性情報を適切に入手できるよう対処し入手した情報を管理している部署ですPharmacovigilancePV安全性業務はGSK製品を使用する患者さんの安全を守る重要な仕事であり日本だけでなく世界各国で厳しい法規制が設けられています我々安全性部門の業務はこれら法規制を守りながらGSK製品の安全性情報を収集評価し適切な対策を実施することですまたAIや自動化の技術を取り入れる等最適なプロセスの構築や効率化を図ることも会社として重要な取り組みとしているためこれらを前向きに業務に取り入れて運用出来る姿勢のある方
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Gsk
You will carry out and oversee quality control testing in our analytical laboratories in Singapore. You will work closely with lab colleagues manufacturing teams and quality partners to ensure accurate compliant and timely release of materials. We value people who are curious reliable
You will carry out and oversee quality control testing in our analytical laboratories in Singapore. You will work closely with lab colleagues manufacturing teams and quality partners to ensure accurate compliant and timely release of materials. We value people who are curious reliable
